Go Deep
IOL Chemicals and Pharmaceuticals Limited
IOL Chemicals and Pharmaceuticals Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 22,480 | 36.8 | 3.44 | 0.07 | 210.50 |
| Oct 2026 | 22,442 | 36.8 | 3.44 | 0.07 | 210.50 |
| Oct 2026 | 22,212 | 35.2 | 3.28 | 0.07 | 201.15 |
IOL Chemicals and Pharmaceuticals Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 7,562,600,000.0 | 6,194,500,000.0 | 5,803,900,000.0 | 5,675,300,000.0 |
| Net Profit | 644,000,000.0 | 531,600,000.0 | 205,800,000.0 | 299,700,000.0 |
| EPS | 2.2 | 1.8 | 0.7 | 1.0 |
IOL Chemicals and Pharmaceuticals Limited Revenue & Profit: Last 4 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | 23,078,100,000.0 | 20,681,900,000.0 | 21,189,600,000.0 | 22,016,900,000.0 |
| Net Profit | 1,376,400,000.0 | 1,010,700,000.0 | 1,344,300,000.0 | 1,391,400,000.0 |
| EPS | 4.7 | 3.4 | 4.6 | 4.7 |
IOL Chemicals and Pharmaceuticals Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 25,869,500,000.0 | 23,820,700,000.0 | 22,444,000,000.0 | 20,221,300,000.0 | — |
| Total Liabilities | 7,884,000,000.0 | 6,944,100,000.0 | 6,328,900,000.0 | 5,144,100,000.0 | — |
| Total Equity | 17,985,500,000.0 | 16,876,600,000.0 | 16,115,100,000.0 | 15,077,200,000.0 | — |
Owes vs Owns
IOL Chemicals and Pharmaceuticals Limited owed ₹0.30 for every ₹1 it owned in Mar 2026, up from ₹0.25 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.30× | 0.29× | 0.28× | 0.25× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
IOL Chemicals and Pharmaceuticals Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 6.2%Receivables 23.3%Inventory 14.3%Fixed assets (tangible) 49.2%Intangible assets 0.6%Long-term investments 2.0%Other assets 4.3%
How it's funded — Mar 2026
Short-term debt 5.1%Payables 18.7%Other liabilities 6.7%Shareholders' equity 69.5%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 161.6 | 162.2 | 115.0 | 18.6 |
| Receivables | 603.1 | 513.7 | 471.2 | 505.3 |
| Inventory | 371.1 | 360.6 | 424.8 | 325.5 |
| Fixed assets (tangible) | 1,272.8 | 1,182.7 | 1,036.5 | 835.4 |
| Intangible assets | 14.7 | 13.6 | 12.8 | 9.0 |
| Long-term investments | 51.7 | 24.4 | 46.5 | 204.1 |
| Other assets | 112.0 | 124.9 | 137.5 | 124.2 |
| Liabilities & equity | ||||
| Short-term debt | 132.0 | 117.0 | 32.8 | 79.6 |
| Long-term debt | 0.0 | 0.0 | 0.0 | 0.0 |
| Payables | 482.6 | 427.6 | 469.2 | 314.2 |
| Other liabilities | 173.8 | 149.8 | 130.9 | 120.6 |
| Shareholders' equity | 1,798.5 | 1,687.7 | 1,611.5 | 1,507.7 |
| Net tangible assets | 1,783.8 | 1,674.1 | 1,598.8 | 1,498.7 |
IOL Chemicals and Pharmaceuticals Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 2,143,200,000.0 | 1,786,200,000.0 | 2,897,800,000.0 | 1,222,700,000.0 | — |
| Investing Activities | -1,981,100,000.0 | -1,541,800,000.0 | -1,909,800,000.0 | -1,200,000,000.0 | — |
| Financing Activities | -290,300,000.0 | 460,400,000.0 | -925,000,000.0 | -41,100,000.0 | — |